Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS)
CNY 9.33
(0.0%)
CNY 9.33
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 16.8 Million CNY | -77.17% |
| 2022 | 73.61 Million CNY | -18.63% |
| 2021 | 90.46 Million CNY | -14.87% |
| 2020 | 106.27 Million CNY | 69.35% |
| 2019 | 62.75 Million CNY | 177.73% |
| 2018 | 22.59 Million CNY | -75.41% |
| 2017 | 91.87 Million CNY | -6.88% |
| 2016 | 98.65 Million CNY | 23.07% |
| 2015 | 80.16 Million CNY | 23.46% |
| 2014 | 64.92 Million CNY | -7.83% |
| 2013 | 70.44 Million CNY | -32.14% |
| 2012 | 103.8 Million CNY | 51.99% |
| 2011 | 68.29 Million CNY | 24.12% |
| 2010 | 55.02 Million CNY | 41.95% |
| 2009 | 38.76 Million CNY | 24.83% |
| 2008 | 31.05 Million CNY | -19.95% |
| 2007 | 38.79 Million CNY | 213.08% |
| 2006 | 12.39 Million CNY | -76.23% |
| 2005 | 52.12 Million CNY | 56.18% |
| 2004 | 33.37 Million CNY | 49.92% |
| 2003 | 22.26 Million CNY | 167.21% |
| 2002 | -33.12 Million CNY | -974.59% |
| 2001 | 3.78 Million CNY | -72.5% |
| 2000 | 13.77 Million CNY | 167.29% |
| 1999 | -20.46 Million CNY | -84.44% |
| 1998 | -11.09 Million CNY | 33.27% |
| 1997 | -16.62 Million CNY | -30.16% |
| 1996 | -12.77 Million CNY | -231.14% |
| 1995 | 9.74 Million CNY | 897.04% |
| 1994 | 977 Thousand CNY | -92.18% |
| 1993 | 12.48 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 76.26 Million CNY | 572.61% |
| 2024 Q2 | 11.64 Million CNY | -56.65% |
| 2024 Q1 | 26.87 Million CNY | 59.91% |
| 2023 Q4 | 16.8 Million CNY | 42.3% |
| 2023 Q1 | 88.58 Million CNY | 20.35% |
| 2023 Q2 | 107.99 Million CNY | 21.91% |
| 2023 FY | 16.8 Million CNY | -77.17% |
| 2023 Q3 | 11.8 Million CNY | -89.07% |
| 2022 Q4 | 73.61 Million CNY | -17.63% |
| 2022 FY | 73.61 Million CNY | -18.63% |
| 2022 Q1 | 98.28 Million CNY | 8.64% |
| 2022 Q2 | 101.35 Million CNY | 3.12% |
| 2022 Q3 | 89.36 Million CNY | -11.83% |
| 2021 Q4 | 90.46 Million CNY | 37.0% |
| 2021 Q1 | 110.12 Million CNY | 3.63% |
| 2021 FY | 90.46 Million CNY | -14.87% |
| 2021 Q2 | 68.68 Million CNY | -37.63% |
| 2021 Q3 | 66.03 Million CNY | -3.86% |
| 2020 FY | 106.27 Million CNY | 69.35% |
| 2020 Q1 | 78.57 Million CNY | 25.21% |
| 2020 Q2 | 92.27 Million CNY | 17.44% |
| 2020 Q3 | 108.49 Million CNY | 17.58% |
| 2020 Q4 | 106.27 Million CNY | -2.04% |
| 2019 Q1 | 19.48 Million CNY | -13.76% |
| 2019 Q4 | 62.75 Million CNY | -15.41% |
| 2019 FY | 62.75 Million CNY | 177.73% |
| 2019 Q3 | 74.18 Million CNY | 14.5% |
| 2019 Q2 | 64.78 Million CNY | 232.5% |
| 2018 Q2 | 109.05 Million CNY | 408.14% |
| 2018 Q1 | 21.46 Million CNY | -76.64% |
| 2018 Q4 | 22.59 Million CNY | -79.34% |
| 2018 FY | 22.59 Million CNY | -75.41% |
| 2018 Q3 | 109.39 Million CNY | 0.31% |
| 2017 Q2 | 127.95 Million CNY | 8.92% |
| 2017 Q4 | 91.87 Million CNY | -17.05% |
| 2017 FY | 91.87 Million CNY | -6.88% |
| 2017 Q1 | 117.46 Million CNY | 19.07% |
| 2017 Q3 | 110.75 Million CNY | -13.44% |
| 2016 Q1 | 92.71 Million CNY | 15.66% |
| 2016 Q2 | 103.85 Million CNY | 12.01% |
| 2016 Q4 | 98.65 Million CNY | -0.04% |
| 2016 Q3 | 98.69 Million CNY | -4.96% |
| 2016 FY | 98.65 Million CNY | 23.07% |
| 2015 FY | 80.16 Million CNY | 23.46% |
| 2015 Q2 | 73.59 Million CNY | 0.97% |
| 2015 Q3 | 86.97 Million CNY | 18.19% |
| 2015 Q4 | 80.16 Million CNY | -7.84% |
| 2015 Q1 | 72.88 Million CNY | 12.26% |
| 2014 Q1 | 78.63 Million CNY | 11.62% |
| 2014 Q2 | 36.11 Million CNY | -54.07% |
| 2014 Q3 | 68.29 Million CNY | 89.11% |
| 2014 FY | 64.92 Million CNY | -7.83% |
| 2014 Q4 | 64.92 Million CNY | -4.92% |
| 2013 Q3 | 72.56 Million CNY | -8.9% |
| 2013 Q4 | 70.44 Million CNY | -2.93% |
| 2013 FY | 70.44 Million CNY | -32.14% |
| 2013 Q1 | 105.91 Million CNY | 2.04% |
| 2013 Q2 | 79.65 Million CNY | -24.79% |
| 2012 FY | 103.8 Million CNY | 51.99% |
| 2012 Q1 | 91.73 Million CNY | 34.32% |
| 2012 Q4 | 103.8 Million CNY | 5.47% |
| 2012 Q2 | 86.68 Million CNY | -5.51% |
| 2012 Q3 | 98.42 Million CNY | 13.55% |
| 2011 FY | 68.29 Million CNY | 24.12% |
| 2011 Q3 | 87.49 Million CNY | 15.64% |
| 2011 Q2 | 75.66 Million CNY | -11.22% |
| 2011 Q4 | 68.29 Million CNY | -21.94% |
| 2011 Q1 | 85.22 Million CNY | 54.88% |
| 2010 FY | 55.02 Million CNY | 41.95% |
| 2010 Q2 | 51.98 Million CNY | -4.77% |
| 2010 Q3 | 60.32 Million CNY | 16.06% |
| 2010 Q4 | 55.02 Million CNY | -8.78% |
| 2010 Q1 | 54.58 Million CNY | 40.8% |
| 2009 Q2 | 18.15 Million CNY | -65.98% |
| 2009 Q3 | 40.47 Million CNY | 122.89% |
| 2009 Q4 | 38.76 Million CNY | -4.21% |
| 2009 FY | 38.76 Million CNY | 24.83% |
| 2009 Q1 | 53.36 Million CNY | 71.85% |
| 2008 Q3 | 46.58 Million CNY | 30.76% |
| 2008 Q1 | 24.59 Million CNY | -36.6% |
| 2008 Q4 | 31.05 Million CNY | -33.33% |
| 2008 FY | 31.05 Million CNY | -19.95% |
| 2008 Q2 | 35.62 Million CNY | 44.84% |
| 2007 Q4 | 38.79 Million CNY | 654.95% |
| 2007 Q3 | 5.13 Million CNY | -39.22% |
| 2007 FY | 38.79 Million CNY | 213.08% |
| 2007 Q2 | 8.45 Million CNY | -81.61% |
| 2007 Q1 | 45.97 Million CNY | 270.98% |
| 2006 Q3 | -13.47 Million CNY | -120.34% |
| 2006 Q1 | 56.92 Million CNY | 9.2% |
| 2006 Q4 | 12.39 Million CNY | 191.94% |
| 2006 FY | 12.39 Million CNY | -76.23% |
| 2006 Q2 | 66.27 Million CNY | 16.43% |
| 2005 Q4 | 52.12 Million CNY | -6.96% |
| 2005 FY | 52.12 Million CNY | 56.18% |
| 2005 Q3 | 56.02 Million CNY | 23.7% |
| 2005 Q2 | 45.28 Million CNY | 1.03% |
| 2005 Q1 | 44.82 Million CNY | 34.32% |
| 2004 Q1 | 38.06 Million CNY | 71.01% |
| 2004 Q2 | 43.42 Million CNY | 14.07% |
| 2004 Q3 | 39.01 Million CNY | -10.15% |
| 2004 FY | 33.37 Million CNY | 49.92% |
| 2004 Q4 | 33.37 Million CNY | -14.46% |
| 2003 Q4 | 22.26 Million CNY | -40.53% |
| 2003 Q1 | -13.7 Million CNY | 58.62% |
| 2003 Q3 | 37.43 Million CNY | 313.45% |
| 2003 Q2 | -17.53 Million CNY | -27.95% |
| 2003 FY | 22.26 Million CNY | 167.21% |
| 2002 FY | -33.12 Million CNY | -974.59% |
| 2002 Q3 | 52.17 Million CNY | 35.29% |
| 2002 Q2 | 38.56 Million CNY | 279.75% |
| 2002 Q1 | 10.15 Million CNY | 168.17% |
| 2002 Q4 | -33.12 Million CNY | -163.48% |
| 2001 Q4 | 3.78 Million CNY | 0.0% |
| 2001 Q2 | 57.28 Million CNY | 0.0% |
| 2001 FY | 3.78 Million CNY | -72.5% |
| 2000 Q4 | 13.77 Million CNY | 0.0% |
| 2000 FY | 13.77 Million CNY | 167.29% |
| 2000 Q2 | 47.64 Million CNY | 0.0% |
| 1999 FY | -20.46 Million CNY | -84.44% |
| 1999 Q2 | 16.88 Million CNY | 0.0% |
| 1999 Q4 | -20.46 Million CNY | 0.0% |
| 1998 FY | -11.09 Million CNY | 33.27% |
| 1998 Q4 | -11.09 Million CNY | 0.0% |
| 1998 Q2 | 14.77 Million CNY | 0.0% |
| 1997 Q4 | -16.62 Million CNY | 0.0% |
| 1997 Q2 | - CNY | 0.0% |
| 1997 FY | -16.62 Million CNY | -30.16% |
| 1996 FY | -12.77 Million CNY | -231.14% |
| 1996 Q4 | -12.77 Million CNY | 0.0% |
| 1996 Q2 | - CNY | 0.0% |
| 1995 FY | 9.74 Million CNY | 897.04% |
| 1995 Q4 | 9.74 Million CNY | 0.0% |
| 1995 Q2 | - CNY | 0.0% |
| 1994 FY | 977 Thousand CNY | -92.18% |
| 1994 Q2 | - CNY | 0.0% |
| 1994 Q4 | 977 Thousand CNY | 0.0% |
| 1993 FY | 12.48 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | -20.67 Billion CNY | 100.081% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 248.15 Million CNY | 93.228% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | -1.53 Billion CNY | 101.095% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | -309.42 Million CNY | 105.431% |
| Aurora Optoelectronics Co.,Ltd. | -251.17 Million CNY | 106.69% |
| NanJing Pharmaceutical Company Limited | 9.24 Billion CNY | 99.818% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 32.59 Million CNY | 48.449% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | -954.2 Million CNY | 101.761% |